135
Participants
Start Date
August 13, 2017
Primary Completion Date
June 30, 2021
Study Completion Date
March 30, 2022
PHMB 0.08%
16 drops in a day in the affected eye for 5 days followed by 8 drops in a day for 7 days,6 drops in a day for 7 days and 4 drops in a day up to clinical resolution
Propamidine 0.1%
16 drops in a day in the affected eye for 5 days followed by 8 drops in a day for 7 days,6 drops in a day for 7 days and 4 drops in a day up to clinical resolution
placebo
16 drops in a day in the affected eye for 5 days followed by 8 drops in a day for 7 days,6 drops in a day for 7 days and 4 drops in a day up to clinical resolution
PHMB 0.02%
16 drops in a day in the affected eye for 5 days followed by 8 drops in a day for 7 days,6 drops in a day for 7 days and 4 drops in a day up to clinical resolution
San Raffaele Hospital, Milan
San Giovanni and Paolo Hospital, Venice
University Clinical Center Medical University of Silesia, Katowice
Moorfields Hospital, London
Manchester Royal Eye Hospital, Manchester
University Hospital Southampton, Southampton
SIFI SpA
INDUSTRY